Operating Income (Loss) in USD of Emmaus Life Sciences, Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • Emmaus Life Sciences, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $695K, a 15.3% decline year-over-year.
  • Emmaus Life Sciences, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$1.21M, a 6833% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2024 was -$1.89M, a 154% decline from 2023.
  • Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2023 was $3.54M.
  • Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2022 was -$6.59M, a 7.47% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Emmaus Life Sciences, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1.21M $695K -$126K -15.3% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$1.09M -$370K -$952K -164% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$134K -$980K +$1.76M +64.2% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$1.89M -$557K -$1.91M -141% 01 Oct 2024 31 Dec 2024 10-K 14 Apr 2025
Q3 2024 $18K $821K +$797K +3321% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$779K $582K -$2.74M -82.5% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $1.97M -$2.74M -$1.58M -135% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $3.54M $1.36M +$2.77M 01 Oct 2023 31 Dec 2023 10-K 14 Apr 2025
Q3 2023 $767K $24K +$684K 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024
Q2 2023 $83K $3.33M +$4.77M 01 Apr 2023 30 Jun 2023 10-Q 10 Sep 2024
Q1 2023 -$4.68M -$1.17M +$1.9M +62% 01 Jan 2023 31 Mar 2023 10-Q 10 Sep 2024
Q4 2022 -$6.59M -$1.42M +$3.55M +71.4% 01 Oct 2022 31 Dec 2022 10-K 03 Jul 2024
Q3 2022 -$10.1M -$660K -$629K -2029% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$9.5M -$1.44M -$1.92M -398% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$7.58M -$3.07M -$1.45M -90% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$6.13M -$4.97M -$5.33M -1475% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$802K -$31K -$39K -488% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$763K $483K +$2.02M 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$2.78M -$1.62M -$2.75M -242% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 -$32K $361K -$339K -48.4% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $307K $8K +$4.06M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$3.75M -$1.54M -$1.65M -1423% 01 Apr 2020 30 Jun 2020 10-Q 01 Sep 2021
Q1 2020 -$2.1M $1.13M +$2.42M 01 Jan 2020 31 Mar 2020 10-Q 01 Sep 2021
Q4 2019 -$4.51M $700K +$3.38M 01 Oct 2019 31 Dec 2019 10-K/A 10 Aug 2021
Q3 2019 -$7.89M -$4.05M -$1.92M -89.9% 01 Jul 2019 30 Sep 2019 10-Q 26 Aug 2021
Q2 2019 -$5.98M $116K +$2.87M 01 Apr 2019 30 Jun 2019 10-Q 26 Aug 2021
Q1 2019 -$8.85M -$1.28M +$1.35M +51.3% 01 Jan 2019 31 Mar 2019 10-Q 26 Aug 2021
Q4 2018 -$10.2M -$2.68M +$74.1K +2.69% 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2019
Q3 2018 -$10.3M -$2.13M +$563K +20.9% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$10.8M -$2.76M -$1.2M -77.4% 01 Apr 2018 30 Jun 2018 8-K/A 14 Aug 2019
Q1 2018 -$9.64M -$2.63M -$1.21M -85.4% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$8.42M -$2.76M -$1.32M -91.9% 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2019
Q3 2017 -$7.1M -$2.69M -$1.05M -63.9% 01 Jul 2017 30 Sep 2017 10-K 11 Dec 2018
Q2 2017 -$6.05M -$1.55M -$745K -92.1% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$5.31M -$1.42M -$730K -106% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 -$4.58M -$1.44M -$811K -130% 01 Oct 2016 31 Dec 2016 10-Q 20 Feb 2018
Q3 2016 -$3.77M -$1.64M -$1.11M -207% 01 Jul 2016 30 Sep 2016 10-K 29 Dec 2017
Q2 2016 -$2.66M -$809K -$253K -45.5% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$2.41M -$690K +$90.1K +11.6% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$2.5M -$625K +$155K +19.8% 01 Oct 2015 31 Dec 2015 10-Q/A 30 Mar 2017
Q3 2015 -$2.65M -$535K +$363K +40.5% 01 Jul 2015 30 Sep 2015 10-K 22 Dec 2016
Q2 2015 -$3.01M -$556K +$459K +45.2% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$3.47M -$780K +$161K +17.1% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$3.63M -$779K +$185K +19.2% 01 Oct 2014 31 Dec 2014 10-Q 17 Feb 2016
Q3 2014 -$3.82M -$898K +$300K +25.1% 01 Jul 2014 30 Sep 2014 10-K 05 Jan 2016
Q2 2014 -$4.12M -$1.01M +$165K +14% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$4.28M -$941K +$184K +16.4% 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015
Q4 2013 -$4.47M -$964K -$265K -37.9% 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2015
Q3 2013 -$4.2M -$1.2M -$163K -15.8% 01 Jul 2013 30 Sep 2013 10-K 29 Dec 2014
Q2 2013 -$4.04M -$1.18M -$26K -2.25% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$4.01M -$1.12M +$209K +15.7% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$4.22M -$699K +$585K +45.6% 01 Oct 2012 31 Dec 2012 10-Q 13 Feb 2014
Q3 2012 -$4.81M -$1.03M -$243K -30.8% 01 Jul 2012 30 Sep 2012 10-K 23 Dec 2013
Q2 2012 -$4.56M -$1.15M +$296K +20.4% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$4.86M -$1.33M +$173K +11.5% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$5.03M -$1.28M +$260K +16.8% 01 Oct 2011 31 Dec 2011 10-Q/A 22 Feb 2013
Q3 2011 -$5.29M -$791K 01 Jul 2011 30 Sep 2011 10-K 15 Jan 2013
Q2 2011 -$1.45M +$10.2K +0.7% 01 Apr 2011 30 Jun 2011 10-Q/A 11 Sep 2012
Q1 2011 -$1.51M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q4 2010 -$1.54M 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012
Q2 2010 -$1.46M 01 Apr 2010 30 Jun 2010 10-Q/A 09 Sep 2011

Emmaus Life Sciences, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.89M -$5.43M -154% 01 Jan 2024 31 Dec 2024 10-K 14 Apr 2025
2023 $3.54M +$10.1M 01 Jan 2023 31 Dec 2023 10-K 14 Apr 2025
2022 -$6.59M -$458K -7.47% 01 Jan 2022 31 Dec 2022 10-K 03 Jul 2024
2021 -$6.13M -$6.1M -19050% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$32K +$4.48M +99.3% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$4.51M +$3.94M +46.6% 01 Jan 2019 31 Dec 2019 10-K/A 10 Aug 2021
2018 -$8.45M -$1.35M -19% 01 Jan 2018 31 Dec 2018 10-K 25 Jan 2021
2017 -$7.1M -$3.34M -88.6% 01 Oct 2016 30 Sep 2017 10-K 11 Dec 2018
2016 -$3.77M -$1.12M -42.2% 01 Oct 2015 30 Sep 2016 10-K 29 Dec 2017
2015 -$2.65M +$1.17M +30.6% 01 Oct 2014 30 Sep 2015 10-K 22 Dec 2016
2014 -$3.82M +$384K +9.14% 01 Oct 2013 30 Sep 2014 10-K 05 Jan 2016
2013 -$4.2M +$605K +12.6% 01 Oct 2012 30 Sep 2013 10-K 29 Dec 2014
2012 -$4.81M +$485K +9.17% 01 Oct 2011 30 Sep 2012 10-K 23 Dec 2013
2011 -$5.29M +$1.21M +18.7% 01 Oct 2010 30 Sep 2011 10-K 15 Jan 2013
2010 -$6.51M 01 Oct 2009 30 Sep 2010 10-K 22 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.